Plasma concentration of intestinal- and liver-FABP in neonates suffering from necrotizing enterocolitis and in healthy preterm neonates

Molecular and Cellular Biochemistry

Volumn 239, Issue 1-2, 2002, Pages 227-234

  Guthmann, Florian ^a   Börchers, Torsten ^b   Wolfrum, Christian ^c   Wustrack, Thomas ^a   Bartholomäus, Sabine ^a   Spener, Friedrich ^c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b ICB Institut fur Chemo und Biosensorik GmbH   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Fatty acid binding protein; Necrotizing enterocolitis; Neonates; Preterm infant; Recombinant protein; Sandwich ELISA

Indexed keywords

FATTY ACID BINDING PROTEIN; RECOMBINANT PROTEIN; CARRIER PROTEIN; FABP1 PROTEIN, HUMAN; FABP1 PROTEIN, MOUSE; FABP7 PROTEIN, HUMAN; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTESTINE; INTESTINE INJURY; LIVER; NECROTIZING ENTEROCOLITIS; NEWBORN; ONSET AGE; PREMATURITY; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; ANIMAL; BLOOD; EVALUATION; GENETICS; GESTATIONAL AGE; INFANT; PATHOLOGY; STATISTICS;

ANIMALS; BIRTH WEIGHT; CARRIER PROTEINS; ENTEROCOLITIS, NECROTIZING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACID-BINDING PROTEINS; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; NEOPLASM PROTEINS; SENSITIVITY AND SPECIFICITY; STATISTICS; TUMOR SUPPRESSOR PROTEINS;

EID: 17644449656     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020508420058     Document Type: Article

References (18)

1. Crissinger KD, Balistreri WF: Gastrointestinal hemorrhage. In: A.A. Fanaroff, R.J. Martin (eds). Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant, 6th edn. Mosby-Year Book Inc., St. Louis, 1997, pp 1331-1333
2. Sacchettini JC, Hauft SM, Van-Camp SL, Cistola DP, Gordon JI: Developmental and structural studies of an intracellular lipid binding protein expressed in the ileal epithelium. J Biol Chem 265: 19199-19207, 1990
3. Kanda T, Nakatomi Y, Ishikawa H, Hitomi M, Matsubara Y, Ono T, Muto T: Intestinal fatty acid-binding protein as a sensitive marker of intestinal ischemia. Dig Dis Sci 37: 1362-1367, 1992
4. Gollin G, Marks C, Marks WH: Intestinal fatty acid binding protein in serum and urine reflects early ischemic injury to the small bowel. Surgery 113: 545-551, 1993
5. Gollin G, Marks WH: Elevation of circulating intestinal fatty acid binding protein in a luminal contents-initiated model of NEC. J Pediatr Surg 28: 367-370, 1993
6. Lieberman JM, Sacchettini J, Marks C, Marks WH: Human intestinal fatty acid binding protein: Report of an assay with studies in normal volunteers and intestinal ischemia. Surgery 121: 335-342, 1997
7. Edelson MB, Sonnino RE, Bagwell CE, Lieberman JM, Marks WH, Rozycki HJ: Plasma intestinal fatty acid binding protein in neonates with necrotizing enterocolitis: a pilot study. J Pediatr Surg 34: 1453-1457, 1999
8. Walsh MC, Kliegman RM: Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 33: 179-201, 1986
9. Wolfrum C, Buhlmann C, Rolf B, Börchers T, Spener F: Variation of liver-type fatty acid binding protein content in the human hepatoma cell line HepG2 by peroxisome proliferators and antisense RNA affects the rate of fatty acid uptake. Biochim Biophys Acta 1437: 194-201, 1999
10. Sweetser DA, Birkenmeier EH, Klisak IJ, Zollman S, Sparkes RS, Mohandas T, Lusis AJ, Gordon JI: The human and rodent intestinal fatty acid binding protein genes. A comparative analysis of their structure, expression, and linkage relationships. J Biol Chem 262: 16060-16071, 1987
11. Gill SC, von Hippel PH: Calculation of protein extinction coefficients from amino acid sequence data. Anal Biochem 182: 319-326, 1989
12. Sonntag J, Wagner MH, Waldschmidt J, Wit J, Obladen M: Multisystem organ failure and capillary leak syndrome in severe necrotizing enterocolitis of very low birth weight infants. J Pediatr Surg 33: 481-484, 1998
13. Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, Tataranni PA, Mochizuki H, Bennett PH, Bogardus C, Prochazka M: An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 95: 1281-1287, 1995
14. Schreiber A, Specht B, Pelsers MMAL, Glatz JFC, Börchers T, Spener F: Recombinant human heart-type fatty acid-binding protein as standard in immunochemical assays. Clin Chem Lab Med 36: 283-288, 1998
15. Kanda T, Fujii H, Tani T, Murakami H, Suda T, Sakai Y, Ono T, Hatakeyama K: Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology 110: 339-343, 1996
16. Poirier H, Degrace P, Niot I, Bernard A, Besnard P: Localization and regulation of the putative membrane fatty-acid transporter (FAT) in the small intestine. Comparison with fatty acid-binding proteins (FABP). Eur J Biochem 238: 368-373, 1996
17. Van Nieuwenhoven FA, Kleine AH, Wodzig WH, Hermens WT, Kragten HA, Maessen JG, Punt CD, Van Dieijen MP, Van der Vusse GJ, Glatz JFC: Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 92: 2848-2854, 1995
18. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L: Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 187: 1-7, 1978